$CRSP
CRISPR Therapeutics AG

2015 Q4 Form 10-K Financial Statement

#000156459017003977 Filed on March 10, 2017

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2015 Q2
Revenue $247.0K $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.200M $2.500M $2.100M
YoY Change
% of Gross Profit
Research & Development $6.200M $3.749M $1.500M
YoY Change
% of Gross Profit
Depreciation & Amortization $60.00K $27.00K $20.00K
YoY Change
% of Gross Profit
Operating Expenses $12.41M $6.202M $3.625M
YoY Change
Operating Profit -$12.17M -$6.202M -$3.625M
YoY Change
Interest Expense -$100.0K -$8.000K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $1.000K $0.00
YoY Change
Pretax Income -$12.20M -$6.201M -$3.600M
YoY Change
Income Tax $100.0K $153.0K $100.0K
% Of Pretax Income
Net Earnings -$12.27M -$6.353M -$3.643M
YoY Change
Net Earnings / Revenue -4967.61%
Basic Earnings Per Share
Diluted Earnings Per Share -$309.8K -$161.2K -$90.68K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q4 2015 Q3 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $156.0M
YoY Change
Cash & Equivalents $156.0M $49.05M
Short-Term Investments
Other Short-Term Assets $500.0K
YoY Change
Inventory
Prepaid Expenses
Receivables $339.0K
Other Receivables $0.00
Total Short-Term Assets $156.8M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $1.328M
YoY Change
Goodwill
YoY Change
Intangibles $454.0K
YoY Change
Long-Term Investments $0.00
YoY Change
Other Assets $101.0K
YoY Change
Total Long-Term Assets $2.583M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $156.8M
Total Long-Term Assets $2.583M
Total Assets $159.4M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.584M
YoY Change
Accrued Expenses $8.430M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.16M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $38.30M
YoY Change
Other Long-Term Liabilities $281.0K
YoY Change
Total Long-Term Liabilities $281.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $10.16M
Total Long-Term Liabilities $281.0K
Total Liabilities $124.0M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$33.91M
YoY Change
Common Stock $4.817M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00
YoY Change
Treasury Stock Shares $0.00
Shareholders Equity -$29.10M
YoY Change
Total Liabilities & Shareholders Equity $159.4M
YoY Change

Cashflow Statement

Concept 2015 Q4 2015 Q3 2015 Q2
OPERATING ACTIVITIES
Net Income -$12.27M -$6.353M -$3.643M
YoY Change
Depreciation, Depletion And Amortization $60.00K $27.00K $20.00K
YoY Change
Cash From Operating Activities $69.01M -$5.320M -$2.680M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$500.0K -$550.0K -$100.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$500.0K -$550.0K -$100.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 38.48M 0.000 52.96M
YoY Change
NET CHANGE
Cash From Operating Activities 69.01M -5.320M -2.680M
Cash From Investing Activities -500.0K -550.0K -100.0K
Cash From Financing Activities 38.48M 0.000 52.96M
Net Change In Cash 107.0M -5.870M 50.18M
YoY Change
FREE CASH FLOW
Cash From Operating Activities $69.01M -$5.320M -$2.680M
Capital Expenditures -$500.0K -$550.0K -$100.0K
Free Cash Flow $69.51M -$4.770M -$2.580M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016Q4 us-gaap Cash
Cash
315520000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3157000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1511000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
320188000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21027000
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
399000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3150000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
198000
CY2016Q4 us-gaap Assets
Assets
344962000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4569000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16320000
CY2016Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
23000
CY2016Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
1027000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
59000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
60000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21998000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10155000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
77646000
CY2016Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
12283000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
189000
CY2016 dei Trading Symbol
TradingSymbol
CRSP
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
695000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-25503000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-7009000
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39810051
CY2016 dei Entity Registrant Name
EntityRegistrantName
CRISPR THERAPEUTICS AG
CY2016Q4 us-gaap Liabilities
Liabilities
112116000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0001674416
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2017Q1 dei Entity Public Float
EntityPublicFloat
605600000
CY2015Q4 us-gaap Cash
Cash
155961000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
339000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
540000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
156840000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1328000
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
454000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
700000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
101000
CY2015Q4 us-gaap Assets
Assets
159423000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1584000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8430000
CY2015Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
81000
CY2015Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
38336000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
75090000
CY2015Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
164000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
281000
CY2015Q4 us-gaap Liabilities
Liabilities
124026000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
1216000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
181000
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
0
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
0
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
288739000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4636000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57083000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33906000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-26000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
232846000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-29097000
CY2015Q4 us-gaap Minority Interest
MinorityInterest
-27000
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
232846000
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-29124000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
344962000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
159423000
CY2016Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
752000
CY2015Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
0
CY2016Q4 crsp Accrued Expenses Related Parties Current
AccruedExpensesRelatedPartiesCurrent
537000
CY2015Q4 crsp Accrued Expenses Related Parties Current
AccruedExpensesRelatedPartiesCurrent
1055000
CY2016Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
0
CY2015Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
97000
CY2016Q4 crsp Deferred Revenue Related Parties Noncurrent
DeferredRevenueRelatedPartiesNoncurrent
527000
CY2015Q4 crsp Deferred Revenue Related Parties Noncurrent
DeferredRevenueRelatedPartiesNoncurrent
0
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.03
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.03
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40253674
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5528079
CY2016 us-gaap Operating Expenses
OperatingExpenses
73294000
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5114000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40164307
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5528079
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39719434
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5528079
CY2016Q4 crsp Common Stock Conditional Capital
CommonStockConditionalCapital
15325607
CY2015Q4 crsp Common Stock Conditional Capital
CommonStockConditionalCapital
2444364
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
444873
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
0
CY2016 us-gaap Revenues
Revenues
5164000
CY2015 us-gaap Revenues
Revenues
247000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42238000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12573000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1513000
CY2015 us-gaap Operating Expenses
OperatingExpenses
25976000
CY2014 us-gaap Operating Expenses
OperatingExpenses
6627000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25834000
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6802000
CY2016 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-25000
CY2015 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-325000
CY2014 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-536000
CY2014 crsp Gain Loss On Extinguishment Of Redeemable Convertible Preferred Shares
GainLossOnExtinguishmentOfRedeemableConvertiblePreferredShares
-745000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-23177000
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.89
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.06
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-6974000
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
1.97
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3684000
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6000
CY2016 crsp Conversion Of Redeemable Convertible Preferred Stock Into Common Stock Shares Value
ConversionOfRedeemableConvertiblePreferredStockIntoCommonStockSharesValue
185565000
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
88664000
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31056000
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13403000
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12257483
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5037404
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
83000
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3559985
CY2016 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1190000
CY2016 crsp Research And Development Expense From Related Party
ResearchAndDevelopmentExpenseFromRelatedParty
1755000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
35000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10844000
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-18000
CY2016Q4 crsp Common Stock Shares Issuance Cost
CommonStockSharesIssuanceCost
8300000
CY2015 crsp Research And Development Expense From Related Party
ResearchAndDevelopmentExpenseFromRelatedParty
1055000
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-581000
CY2014 crsp Receipt Of Common Shares Subscription Receivables
ReceiptOfCommonSharesSubscriptionReceivables
22000
CY2014 crsp Gain Loss On Extinguishment Of Preferred Shares
GainLossOnExtinguishmentOfPreferredShares
-745000
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-68130000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-25729000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-6627000
CY2016 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8050000
CY2015 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-108000
CY2016 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-36532000
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
11482000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
78512000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16000
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-236000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
45412000
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-92000
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-236000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22718000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25821000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6863000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
484000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-63000
CY2016 us-gaap Profit Loss
ProfitLoss
-23202000
CY2015 us-gaap Profit Loss
ProfitLoss
-25828000
CY2014 us-gaap Profit Loss
ProfitLoss
-6800000
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-18000
CY2015 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000
CY2014 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23220000
CY2015 us-gaap Paid In Kind Interest
PaidInKindInterest
97000
CY2016 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-2000
CY2015 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
20000
CY2016 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
2450000
CY2015 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
650000
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
38000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
925000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
127000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
10844000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
3684000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
695000
CY2016 us-gaap Paid In Kind Interest
PaidInKindInterest
8050000
CY2014 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
260000
CY2016 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
78608000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2818000
CY2016 crsp Income Loss From Equity Method Investments And Investment Compensation Expense
IncomeLossFromEquityMethodInvestmentsAndInvestmentCompensationExpense
-36380000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
339000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1071000
CY2014 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
16000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
620000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12000
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3860000
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7708000
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1583000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1917000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
75090000
CY2016 crsp Increase Decrease In Deferred Rent Payable
IncreaseDecreaseInDeferredRentPayable
2360000
CY2015 crsp Increase Decrease In Deferred Rent Payable
IncreaseDecreaseInDeferredRentPayable
165000
CY2016 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-17000
CY2015 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
14000
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-21000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-55310000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
59428000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4793000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3016000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1154000
CY2016 crsp Proceeds From Contribution Of Intellectual Property To Equity Method Investee
ProceedsFromContributionOfIntellectualPropertyToEquityMethodInvestee
35000000
CY2016 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
100000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
31884000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1154000
CY2016 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
54061000
CY2016 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
35000000
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
34000
CY2015 crsp Proceeds From Issuance Of Restricted Shares
ProceedsFromIssuanceOfRestrictedShares
243000
CY2016 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
1810000
CY2015 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
370000
CY2014 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
36000
CY2016 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
35010000
CY2015 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
38239000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
183220000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
96733000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5123000
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-235000
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
9000
CY2014 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
254000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
159559000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
155016000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
584000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155961000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
945000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
361000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
315520000
CY2016 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7014000
CY2015 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
246000
CY2016 crsp Property And Equipment Related To Lease Incentives
PropertyAndEquipmentRelatedToLeaseIncentives
10785000
CY2016 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
185565000
CY2016 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
61929000
CY2016 crsp Issuance Costs For Initial Public Offering In Accounts Payable And Accrued Expenses
IssuanceCostsForInitialPublicOfferingInAccountsPayableAndAccruedExpenses
397000
CY2016 crsp Noncash Contribution Of Intellectual Property To Equity Method Investee
NoncashContributionOfIntellectualPropertyToEquityMethodInvestee
36380000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-6353000
CY2015Q3 us-gaap Profit Loss
ProfitLoss
-6354000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
3625000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
6202000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3736000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3625000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6202000
CY2015Q1 us-gaap Profit Loss
ProfitLoss
-3522000
CY2015Q2 us-gaap Profit Loss
ProfitLoss
-3666000
CY2016 crsp Operating Lease Number Of Leases
OperatingLeaseNumberOfLeases
5
CY2016Q4 crsp Number Of Expiring Leases
NumberOfExpiringLeases
3
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
6685000
CY2014 us-gaap Depreciation
Depreciation
0
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2585000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1300000
CY2016 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-bottom:0pt;margin-top:18pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reclassifications </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A change has been made to the presentation of deferred rent non-current as of December 31, 2015 to conform to the current year presentation. </p></div>
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
773000
CY2016Q4 crsp Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
996000
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-bottom:0pt;margin-top:18pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risk and Off-balance Sheet Risk </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash. The Company&#8217;s cash is held in accounts with financial institutions that management believes are creditworthy. The Company has not experienced any credit losses in such accounts and does not believe it is exposed to any significant credit risk on these funds. The Company has no financial instruments with off-balance sheet risk of loss. </p></div>
CY2015Q4 crsp Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
910000
CY2016Q4 crsp Accrued License Fees Current
AccruedLicenseFeesCurrent
492000
CY2015Q4 crsp Accrued License Fees Current
AccruedLicenseFeesCurrent
1055000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2715000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2412000
CY2016Q4 crsp Accrued Intellectual Property Costs Current
AccruedIntellectualPropertyCostsCurrent
3372000
CY2015Q4 crsp Accrued Intellectual Property Costs Current
AccruedIntellectualPropertyCostsCurrent
2592000
CY2016Q4 crsp Accrued Property And Equipment
AccruedPropertyAndEquipment
5081000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
72000
CY2016 us-gaap Depreciation
Depreciation
900000
CY2015 us-gaap Depreciation
Depreciation
100000
CY2016 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2013-10-28
CY2016 dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Basel, Switzerland
CY2016Q4 us-gaap Cash
Cash
315500000
CY2016 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
3.33
CY2016 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
3 1/3-for-one
CY2016 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2015Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
156000000
CY2016Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
315500000
CY2016 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2015 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2014 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2016 crsp Number Of Equity Based Compensation Awards
NumberOfEquityBasedCompensationAwards
8
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4624738
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25358808
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3560002
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21969000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1400000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
942000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1079000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
688000
CY2015Q4 crsp Proceeds Raised From Investors
ProceedsRaisedFromInvestors
5000000
CY2016 crsp Cost Sharing Expenses Incurred
CostSharingExpensesIncurred
3000000
CY2016 crsp Operating Lease Expiration Year
OperatingLeaseExpirationYear
2017
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
4200000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
17000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
6431000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
6624000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
6823000
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-2000
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-26000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
7027000
CY2014 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-74000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
30335000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
63925000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-22718000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-25821000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6863000
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
61000
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
11000
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
649000
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
23000
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-11000
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
12000
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-17000
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
26000
CY2014 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
11000
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
621000
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-30000
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
37000
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-105000
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-65000
CY2015 crsp Cost Sharing Expenses Incurred
CostSharingExpensesIncurred
1500000
CY2014 crsp Cost Sharing Expenses Incurred
CostSharingExpensesIncurred
1100000
CY2016 crsp Cost Sharing Expenses Accrued
CostSharingExpensesAccrued
2800000
CY2015 crsp Cost Sharing Expenses Accrued
CostSharingExpensesAccrued
2600000
CY2016 us-gaap Research And Development Arrangement Contract To Perform For Others Description And Terms
ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms
The research collaboration will end on the earlier of the date on which Vertex has exercised six options to obtain exclusive/co-exclusive licenses with respect to a collaboration target, or the fourth anniversary of the effective date of the agreement. The research term may be extended as mutually agreed by the parties up to nine additional months to complete any research activities under the approved research plan that are incomplete on the fourth anniversary of the effective date.
CY2016 crsp Joint Venture Agreement Date
JointVentureAgreementDate
2015-12-19
CY2016Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure
91200000
CY2016Q4 crsp Remaining License Fee
RemainingLicenseFee
15000000
CY2016Q4 us-gaap Equity Method Investments
EquityMethodInvestments
36500000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
18837024
CY2015Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
18837024
CY2016Q4 crsp Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Unvested Restricted Share Award Not Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsUnvestedRestrictedShareAwardNotOutstanding
89367
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
15325607
CY2015Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2444364
CY2016Q4 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
170689
CY2016Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0
CY2016 us-gaap Common Stock Voting Rights
CommonStockVotingRights
One vote for each common share
CY2016 us-gaap Dividends
Dividends
0
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10844000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3684000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
695000
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
23400000
CY2016 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y3M18D
CY2016 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
100000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
3322000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
593000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-26040000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-26414000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-6863000
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.103
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.000
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.016
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.000
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.000
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.103
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.013
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-54000
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.001
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-137000
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-74000
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.103
CY2016 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.033
CY2015 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.014
CY2014 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.018
CY2016 crsp Effective Income Tax Rate Reconciliation Statutory Permanent Differences
EffectiveIncomeTaxRateReconciliationStatutoryPermanentDifferences
0.066
CY2015 crsp Effective Income Tax Rate Reconciliation Statutory Permanent Differences
EffectiveIncomeTaxRateReconciliationStatutoryPermanentDifferences
0.000
CY2014 crsp Effective Income Tax Rate Reconciliation Statutory Permanent Differences
EffectiveIncomeTaxRateReconciliationStatutoryPermanentDifferences
0.000
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.049
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.014
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.011
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.031
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.006
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.000
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.168
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.082
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.101
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.021
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.009
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3934000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2600000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
791000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
189000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
5228000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
7000
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
72000
CY2016Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
2525000
CY2015Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
406000
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
425000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
104000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
12910000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3371000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6770000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2892000
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
6140000
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
479000
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
5909000
CY2015Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
321000
CY2016Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
68000
CY2015Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
80000
CY2015Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
53000
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
5977000
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
454000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
163000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
25000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
41700000
CY2016 crsp Operating Loss Carryforwards Expiration Period
OperatingLossCarryforwardsExpirationPeriod
2020
CY2016Q4 crsp Deferred Tax Assets Operating Loss Carryforwards Domestic State Research And Development
DeferredTaxAssetsOperatingLossCarryforwardsDomesticStateResearchAndDevelopment
200000
CY2016 crsp Research And Development Credit Carryforwards Expiration Period
ResearchAndDevelopmentCreditCarryforwardsExpirationPeriod
2031
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
163000
CY2016Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
100000
CY2016Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2015Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2014Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2016Q4 crsp Uncertain Tax Position Recognized
UncertainTaxPositionRecognized
0
CY2015Q4 crsp Uncertain Tax Position Recognized
UncertainTaxPositionRecognized
0
CY2014Q4 crsp Uncertain Tax Position Recognized
UncertainTaxPositionRecognized
0
CY2015Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5528079
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5528079
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
49000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
134000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
49000
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
20000
CY2016Q4 crsp Net Income Loss Attributable To Participating Securities Excluded From Numerator For Calculating Basic Net Income Loss Per Share
NetIncomeLossAttributableToParticipatingSecuritiesExcludedFromNumeratorForCalculatingBasicNetIncomeLossPerShare
3100000
CY2016Q4 crsp Net Income Loss Attributable To Participating Securities Excluded From Numerator For Calculating Diluted Net Income Loss Per Share
NetIncomeLossAttributableToParticipatingSecuritiesExcludedFromNumeratorForCalculatingDilutedNetIncomeLossPerShare
3100000
CY2016Q3 us-gaap Profit Loss
ProfitLoss
-14694000
CY2016Q4 us-gaap Profit Loss
ProfitLoss
17098000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-14680000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
17099000
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.77
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.77
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5292348
CY2016Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32987335
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5292348
CY2016Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34989218
CY2015Q4 us-gaap Revenues
Revenues
247000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
3736000
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
12413000
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-12166000
CY2015Q4 us-gaap Profit Loss
ProfitLoss
-12286000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-3237000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-3643000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-12270000
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.91
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.80
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.15
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.22
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3560000
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4538595

Files In Submission

Name View Source Status
0001564590-17-003977-index-headers.html Edgar Link pending
0001564590-17-003977-index.html Edgar Link pending
0001564590-17-003977.txt Edgar Link pending
0001564590-17-003977-xbrl.zip Edgar Link pending
crsp-10k_20161231.htm Edgar Link pending
crsp-20161231.xml Edgar Link completed
crsp-20161231.xsd Edgar Link pending
crsp-20161231_cal.xml Edgar Link unprocessable
crsp-20161231_def.xml Edgar Link unprocessable
crsp-20161231_lab.xml Edgar Link unprocessable
crsp-20161231_pre.xml Edgar Link unprocessable
crsp-ex211_1002.htm Edgar Link pending
crsp-ex231_1001.htm Edgar Link pending
crsp-ex232_1000.htm Edgar Link pending
crsp-ex311_1005.htm Edgar Link pending
crsp-ex312_1004.htm Edgar Link pending
crsp-ex321_1003.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2017031018565602831417.jpg Edgar Link pending
g2017031018565604131418.jpg Edgar Link pending
g2017031018565605831419.jpg Edgar Link pending
g2017031018565609031420.jpg Edgar Link pending
g2017031018565610431421.jpg Edgar Link pending
g2017031018565611531422.jpg Edgar Link pending
g2017031018565612831423.jpg Edgar Link pending
g2017031018565615231424.jpg Edgar Link pending
g2017031018565619431425.jpg Edgar Link pending
g2017031018571013731426.jpg Edgar Link pending
g2017031018571653731427.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending